BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 19661489)

  • 1. Tissue factor and PAR2 signaling in the tumor microenvironment.
    Schaffner F; Ruf W
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):1999-2004. PubMed ID: 19661489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue factor and protease-activated receptor signaling in cancer.
    Schaffner F; Ruf W
    Semin Thromb Hemost; 2008 Mar; 34(2):147-53. PubMed ID: 18645919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation of tissue factor-factor VIIa-factor Xa complex promotes cellular signaling and migration of human breast cancer cells.
    Jiang X; Bailly MA; Panetti TS; Cappello M; Konigsberg WH; Bromberg ME
    J Thromb Haemost; 2004 Jan; 2(1):93-101. PubMed ID: 14717972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin generation and the pathogenesis of cancer.
    Ruf W; Mueller BM
    Semin Thromb Hemost; 2006 Apr; 32 Suppl 1():61-8. PubMed ID: 16673267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.
    Morris DR; Ding Y; Ricks TK; Gullapalli A; Wolfe BL; Trejo J
    Cancer Res; 2006 Jan; 66(1):307-14. PubMed ID: 16397244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering of substrate selectivity for tissue factor.factor VIIa complex signaling through protease-activated receptor 2.
    Larsen KS; Ostergaard H; Olsen OH; Bjelke JR; Ruf W; Petersen LC
    J Biol Chem; 2010 Jun; 285(26):19959-66. PubMed ID: 20388709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of protease activated receptor 1 and 2 signaling in hypoxia-induced angiogenesis.
    Uusitalo-Jarvinen H; Kurokawa T; Mueller BM; Andrade-Gordon P; Friedlander M; Ruf W
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1456-62. PubMed ID: 17363687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue factor in cancer progression and angiogenesis.
    Ruf W; Yokota N; Schaffner F
    Thromb Res; 2010 Apr; 125 Suppl 2(0 2):S36-8. PubMed ID: 20434002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease-activated receptor 2 (PAR2) mediates vascular smooth muscle cell migration induced by tissue factor/factor VIIa complex.
    Marutsuka K; Hatakeyama K; Sato Y; Yamashita A; Sumiyoshi A; Asada Y
    Thromb Res; 2002 Sep; 107(5):271-6. PubMed ID: 12479889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cooperation of tissue factor cytoplasmic domain and PAR2 signaling in breast cancer development.
    Schaffner F; Versteeg HH; Schillert A; Yokota N; Petersen LC; Mueller BM; Ruf W
    Blood; 2010 Dec; 116(26):6106-13. PubMed ID: 20861457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor VIIa/tissue factor-induced signaling: a link between clotting and disease.
    Pendurthi UR; Rao LV
    Vitam Horm; 2002; 64():323-55. PubMed ID: 11898395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa.
    Camerer E; Huang W; Coughlin SR
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5255-60. PubMed ID: 10805786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matriptase activation connects tissue factor-dependent coagulation initiation to epithelial proteolysis and signaling.
    Le Gall SM; Szabo R; Lee M; Kirchhofer D; Craik CS; Bugge TH; Camerer E
    Blood; 2016 Jun; 127(25):3260-9. PubMed ID: 27114461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of tissue factor-induced signaling by endogenous and recombinant tissue factor pathway inhibitor 1.
    Ahamed J; Belting M; Ruf W
    Blood; 2005 Mar; 105(6):2384-91. PubMed ID: 15550483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue factor trafficking in fibroblasts: involvement of protease-activated receptor-mediated cell signaling.
    Mandal SK; Pendurthi UR; Rao LV
    Blood; 2007 Jul; 110(1):161-70. PubMed ID: 17384202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protease-activated receptor 2-dependent phosphorylation of the tissue factor cytoplasmic domain.
    Ahamed J; Ruf W
    J Biol Chem; 2004 May; 279(22):23038-44. PubMed ID: 15039423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional program induced by factor VIIa-tissue factor, PAR1 and PAR2 in MDA-MB-231 cells.
    Albrektsen T; Sørensen BB; Hjortø GM; Fleckner J; Rao LV; Petersen LC
    J Thromb Haemost; 2007 Aug; 5(8):1588-97. PubMed ID: 17470200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tick-derived inhibitor Ixolaris prevents tissue factor signaling on tumor cells.
    Carneiro-Lobo TC; Schaffner F; Disse J; Ostergaard H; Francischetti IM; Monteiro RQ; Ruf W
    J Thromb Haemost; 2012 Sep; 10(9):1849-58. PubMed ID: 22823596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase-2: A key regulator in coagulation proteases mediated human breast cancer progression through autocrine signaling.
    Das K; Prasad R; Ansari SA; Roy A; Mukherjee A; Sen P
    Biomed Pharmacother; 2018 Sep; 105():395-406. PubMed ID: 29870887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of tissue factor in cancer.
    Kasthuri RS; Taubman MB; Mackman N
    J Clin Oncol; 2009 Oct; 27(29):4834-8. PubMed ID: 19738116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.